Arkolith/Insider Trading/ITCI/Form 4

Durgam Suresh K.

EVP, Chief Medical OfficerIntra-Cellular Therapies, Inc. (ITCI) · full profile →Form 4 · filed Apr 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
1 non-derivative · 11 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2025Disposed to issuer(D)43K$132.00$5.7M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 2, 2025Disposed to issuer(D)33K——0
Apr 2, 2025Disposed to issuer(D)13K——0
Apr 2, 2025Grant(A)13K—$013K
Apr 2, 2025Disposed to issuer(D)25K——0
Apr 2, 2025Disposed to issuer(D)17K——0
Apr 2, 2025Disposed to issuer(D)13K——0
Apr 2, 2025Disposed to issuer(D)18K——0
Apr 2, 2025Disposed to issuer(D)19K——0
Apr 2, 2025Disposed to issuer(D)9K——0
Apr 2, 2025Grant(A)9K—$09K
Apr 2, 2025Disposed to issuer(D)54K——0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-049593) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML